All News

CDC publishes a schedule of recommended immunizations, how many doses are required, and at what age they should be administered.

The FDA approved pembrolizumab plus lenvatinib for the first-line treatment of adult patients with advanced RCC.

In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.

Pharmacists are in a strong position to identify the early warning signs of diabetes because they are often the most accessible and frequently visited members of the health care team.

New potential medications may continue to expand the role of targeted agents.

Patients with microsatellite stable (MSS) colorectal cancer, which represents 95% of all metastatic colorectal cancer cases, are more responsive to checkpoint blockade immunotherapy if the patient’s tumors have not spread to the liver.

Pharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.

The investigators found that antibodies generated by a single dose of the Pfizer-BioNTech vaccine was less effective at neutralizing variants of concern, but the second dose dramatically increased responses to virus variants.

The FDA is expected to recommend that individuals with compromised immune systems receive a booster shot of either the Pfizer or Moderna COVID-19 vaccine.

Antonio Ciaccia, CEO of 46brooklyn Research, discusses his company’s efforts to uncover and understand the structure that underlies US drug pricing distortions.

On August 4, 2021, the Biden administration expanded the authority of pharmacy technicians under the PREP Act to allow pharmacy technicians to administer adult flu vaccines during the 2021-2022 flu season.

The CDC now recommends COVID-19 vaccination for all individuals 12 years and older in the United States, including those who are pregnant or breastfeeding.

Sharon Park, PharmD, MEd, BCPS, , associate professor and assistant dean for academic affairs at the Notre Dame of Maryland University School of Pharmacy, discusses career options for pharmacy students outside of the traditional roles of a pharmacist.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, assistant professor of pharmacy practice at Loma Linda University School of Pharmacy, discusses the importance of Black pharmacists in creating equitable access to COVID-19 vaccinations.

The introduction of a biosimilar insulin could result in major shifts in the accessibility and affordability of insulin for all patients.

If approved, pembrolizumab would be the first adjuvant immunotherapy option for this patient population with renal cell carcinoma.

The safety of atezolizumab in the Impower010 trial was consistent with its known safety profile and no new safety signals were identified.

Among those who had hypertension, diabetes, and/or obesity as well as COVID-19, the risk rose to 160%.

The requirement to promote a healthy, productive, and safe work environment is borne by all, not just those with a managerial title.

Current guideline recommendations include various combinations of targeted therapy with immunotherapy.

Study suggests that immediate onset mRNA vaccine reactions may not be caused by classic allergy, or IgE-mediated hypersensitivity.

The Independent Data Monitoring Committee concluded that DESTINY-Breast03 met the primary endpoint of progression-free survival and showed a highly statistically significant and clinically meaningful improvement for patients with human epidermal growth factor receptor 2 (HER2)-positive, unresectable and/or metastatic breast cancer previously treated with trastuzumab and a taxane.

The strongest associations with attention-deficit hyperactivity disorder were present for nervous system, respiratory, musculoskeletal, and metabolic diseases.

The goal of treating heart failure is to reduce symptoms, improve heart function, and increase ejection fraction.

A panel of key stakeholders in the pharmacy field discuss the nature of environmental conditions as a social determinant of health and the potential impact on patient health outcomes, as well as how to best educate patients and colleagues when approaching the subject in the pharmacy.

A number of prescription medications are indicated for the treatment of this aggressive disease.

The investigators examined data from more than 50,000 individuals participating in the Danish Diet, Cancer, and Health study over a 23-year period.

Polatuzumab vedotin regimen is the first in 2 decades to show such significant improvements.